Effects of probiotics on postoperative inflammation, gut microbiota, and clinical outcomes in patients with colorectal cancer: a systematic review and meta-analysis
Authors: Wang, Qiuxiang; Ou, Yuhong; Chen, Xuping; Xiang, Yongguo; Wang, Chunfeng; Li, Zhishu; He, Shixu
Source journal: Frontiers in oncology (2026-01-01)
DOI: 10.3389/fonc.2026.1936090
Abstract
BACKGROUND: Perioperative probiotics for CRC surgery may modulate gut microbiota, yet evidence for inflammation, complications is inconsistent. We systematically assessed these outcomes. METHODS: Following PRISMA guidelines, we searched PubMed, Embase, Cochrane Library, and Web of Science for randomized controlled trials (RCTs). A random-effects model was applied. RESULTS: Probiotics reduced interleukin-6 (MD: -7.52, 95% CI: -14.18 to -0.86; P = 0.03) and white blood cell count (MD: -1.18, 95% CI: -1.90 to -0.46; P = 0.001), but not C-reactive protein. Incidence of infectious complications lowered: pneumonia (OR: 0.41, 95% CI: 0.25 to 0.68; P = 0.0005), urinary tract infection (OR: 0.40, 95% CI: 0.18 to 0.88; P = 0.02), surgical site infection (OR: 0.54, 95% CI: 0.39 to 0.74; P = 0.0002), bacteremia (OR: 0.37, 95% CI: 0.16 to 0.86; P = 0.02), and septicemia (OR: 0.27, 95% CI: 0.13 to 0.57; P = 0.0007). Probiotics also shortened postoperative pyrexia duration (MD: -0.89, 95% CI: -1.32 to -0.47; P<0.001) and cumulative antibiotic therapy (MD: -1.42, 95% CI: -1.80 to -1.03; P<0.001). Gut microbiota analysis showed increased Bifidobacterium (MD: 1.38, 95% CI: 0.31 to 2.45; P = 0.01) and decreased Enterobacteriaceae (MD: -1.41, 95% CI: -2.11 to -0.71; P<0.001). Intestinal barrier function improved, with reduced bacterial translocation (OR: 0.24, 95% CI: 0.07 to 0.88; P = 0.03) and lower serum zonulin (MD: -0.81, 95% CI: -1.03 to -0.58; P<0.001). Non-infectious symptoms including diarrhea (OR: 0.38, 95% CI: 0.25 to 0.57; P<0.001) and abdominal distension (OR: 0.53, 95% CI: 0.33 to 0.83; P = 0.006) were reduced. Clinical recovery accelerated: shorter hospital stay (MD: -1.06, 95% CI: -1.69 to -0.43; P = 0.001), earlier first flatus (MD: -0.41, 95% CI: -0.70 to -0.12; P = 0.005), first defecation (MD: -0.83, 95% CI: -1.52 to -0.15; P = 0.02), and faster fluid diet tolerance (MD: -0.28, 95% CI: -0.41 to -0.15; P<0.001).Anastomotic leak was not significantly reduced (OR: 0.61, 95% CI: 0.32 to 1.14; P = 0.12). CONCLUSION: Perioperative probiotic supplementation in CRC patients may reduce postoperative inflammation, lower infectious complication rates, improve gut microbiota composition and intestinal barrier function, alleviate non-infectious symptoms, and accelerate clinical recovery. Notwithstanding these observed benefits, pooled results should be interpreted with extreme caution because of substantial heterogeneity. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261379777, identifier CRD420261379777.
Related topics
Related open access articles
- The effects of a marine photosynthetic bacteria Rhodovulum sulfidophilum on the growth and survival rate of Marsupenaeus japonicus (kuruma shrimp)
- An Extended Taxonomic Profile and Metabolic Potential Analysis of Pulque Microbial Community Using Metagenomics
- Impacts of probiotics on feeding technology and its application in aquaculture
- Towards diversification of aquaculture in Ghana: Reproductive response of Sarotherodon melanotheron to locally formulated fish feed
- Grading frequency affect the growth performance and intra−cohort cannibalism in African catfish (Clarias gariepinus, burchell, 1822) culture
- Practical and essential information on water reuse systems in experimental aquaculture production: a descriptive review
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.